DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas to moderate panel, “Accessing Capital through Risk-Sharing Models between Early-Stage Companies and Contract Research Organizations” at BIO 2010 in Chicago, IL
News | 05. 05. 2010
